Finally, we established a new and effective therapeutic approach to decrease metastasis and tumor self-seeding by combining SB431542 and DMA at low, suboptimal doses, which simultaneously target TGF-β signaling and sEV trafficking. This evidence concerns the gene TGFB1 and neoplasm.